Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sabutoclax: Pan-Bcl-2 Inhibitor for Apoptosis Workflows
2026-07-28
Sabutoclax redefines apoptosis studies by targeting multiple Bcl-2 family proteins with high potency and selectivity. Its superior cell permeability and validated in vitro and in vivo efficacy make it a versatile tool for translational cancer research and preclinical modeling.
-
Canagliflozin Hemihydrate: Precision Tool for SGLT2 Research
2026-07-28
Explore the unique research-grade properties of Canagliflozin hemihydrate, an advanced SGLT2 inhibitor optimized for glucose metabolism research. This article offers new insights on selectivity, assay design, and the latest findings on its mechanistic boundaries.
-
Elobixibat Hydrate: Mechanisms, Metabolic Impact, and Clinic
2026-07-27
Explore the multifaceted action of Elobixibat hydrate, a leading ileal bile acid transporter inhibitor, with a scientific deep dive into its mechanisms, clinical outcomes, and metabolic benefits. This article uniquely combines mechanistic insight with translational implications for chronic idiopathic constipation and metabolic diseases.
-
Pioglitazone as a PPARγ Agonist: Innovations in Macrophage P
2026-07-27
Explore how Pioglitazone, a potent PPARγ agonist, uniquely advances studies of macrophage polarization and inflammatory modulation. This article delivers a deeper mechanistic analysis, practical assay insights, and fresh perspectives on metabolic and neuroinflammatory research applications.
-
Y-27632 Dihydrochloride: ROCK Inhibition for Advanced Cell M
2026-07-26
Y-27632 dihydrochloride distinguishes itself as a benchmark ROCK inhibitor for dissecting cytoskeletal regulation, stem cell viability, and cancer invasion in both 2D and 3D cell culture systems. This article delivers a workflow-centric guide, actionable troubleshooting, and practical integration of recent findings—empowering researchers in regenerative medicine and neurodevelopmental disease modeling.
-
Trelagliptin Succinate: Mechanistic Advances and Translation
2026-07-25
This thought-leadership article guides translational diabetes researchers through the mechanistic rationale, experimental best practices, and translational relevance of Trelagliptin succinate (SYR-472 succinate). Integrating validated protocol parameters, competitive insights, and a forward-looking outlook, it positions APExBIO’s high-purity Trelagliptin succinate as a critical enabler for metabolic, inflammatory, and neurocognitive research workflows.
-
PEGylated Iron Oxide Nanoparticles: Hepatic Cellular Uptake
2026-07-24
This study systematically dissects how size and PEG chain length control hepatic accumulation and cellular uptake of iron oxide nanoparticles. Its findings challenge conventional views of liver clearance, offering actionable design parameters for nanomedicine delivery and biosafety optimization.
-
Brassinolide: Mechanisms and Strategic Use in Translational
2026-07-24
This thought-leadership article explores brassinolide's dual impact as a plant growth regulator and apoptosis inducer in cancer and metabolic disease models. Drawing on recent structure–activity research and validated workflows, it provides actionable guidance for translational researchers seeking robust, cross-domain applications. The article differentiates itself by integrating mechanistic insights, protocol parameters, and strategic perspectives, advancing the conversation beyond standard product literature.
-
A-1331852: Precision BCL-XL Inhibitor Workflows in Apoptosis
2026-07-23
A-1331852 empowers cancer research with selective, nanomolar-potency BCL-XL inhibition, outperforming earlier tools in both sensitivity and specificity for apoptosis and senescence studies. This guide distills the latest experimental advances—protocols, troubleshooting, and comparative insights—for researchers seeking robust, reproducible results in apoptosis assays.
-
Tetracycline: Broad-Spectrum Polyketide Antibiotic in Resear
2026-07-23
Tetracycline stands out as a versatile tool for antibiotic selection and ribosome-targeted research, enabling precise control in complex molecular biology assays. APExBIO's high-purity formulation offers unmatched reliability, integrating seamlessly with advanced protocols and troubleshooting demands.
-
Aminopeptidase Inhibition Enhances Angiotensin Signaling in
2026-07-22
Harding and Felix (1987) revealed that Bestatin hydrochloride, an aminopeptidase B inhibitor, amplifies neuronal responses to angiotensin II and III in the rat brain. This work clarifies that enzymatic conversion to angiotensin III is essential for central angiotensin activity, providing mechanistic insight for neuroendocrine and cardiovascular research.
-
Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Workflow & Signal Ga
2026-07-22
Unlock next-level sensitivity in immunohistochemistry and cell-based assays using the Cy5 Goat Anti-Mouse IgG (H+L) Antibody. This Cy5-conjugated secondary antibody enables robust fluorescent signal amplification, streamlining multiplexed workflows and troubleshooting for challenging mouse IgG detection.
-
Camostat Mesilate: Applied Workflows for Protease Inhibition
2026-07-21
Camostat Mesilate stands out as a potent trypsin-like protease inhibitor, enabling precise studies of airway ENaC function and TGF-β signaling suppression. This article delivers stepwise workflows, troubleshooting insights, and advanced protocol guidance for maximizing reliability and interpretability in fibrosis and airway research.
-
Canagliflozin (hemihydrate): SGLT2 Inhibitor in Glucose Meta
2026-07-21
Canagliflozin hemihydrate is a high-purity SGLT2 inhibitor essential for glucose metabolism and diabetes mellitus research. It acts by selectively inhibiting renal glucose reabsorption, with validated specificity distinct from mTOR-targeted mechanisms. This dossier details its properties, mechanistic profile, and limitations for translational research.
-
DiR (DiIC 18 (7)): Deep-Red Probe Transforming Membrane Imag
2026-07-20
Discover how DiR (DiIC 18 (7)) is revolutionizing long-term cell membrane staining, with unique mechanistic insights and advanced applications in live and fixed tissue imaging. Explore new assay strategies and scientific findings that set this product apart.
8139 records 7/543 page Previous Next First page 上5页 678910 下5页 Last page